Detailansicht

Wissensnetz

Person

Wolfgang Schultze-Seemann

Urologe

Name	Wolfgang Schultze-Seemann
Ort	Deutschland
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Urologe (charakteristischer Beruf)
Variante	Wolfgang Schultze- Seemann
Beziehung	Universitätsklinikum Freiburg. Klinik für Urologie
Weitere Angaben	Stellvertretender Ärztlicher Direktor - Sektionsleiter Urologische Onkologie
Datensatztyp	Person
GND-Nummer	1117245195
Datensatz-ID	1117245195
Beteiligt an alle anzeigen Comprehensive analysis of complications after transperineal prostate biopsy without antibiotic prophylaxis: results of a multicenter trial with 30 days’ follow-up Real-world data on the use of nivolumab monotherapy in the treatment of advanced renal cell carcinoma after prior therapy: interim results from the Noninterventional NORA Study Recruitment of activated oncogenes and their splice variants to different EV populations Stereotactic body radiotherapy for renal cell carcinoma in patients with von Hippel–Lindau disease - results of a prospective trial 99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle 99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle A multi-institutional analysis of prostate cancer patients with or without 68Ga-PSMA PET/CT prior to salvage radiotherapy of the prostatic fossa A multi-institutional analysis of prostate cancer patients with or without 68Ga-PSMA PET/CT prior to salvage radiotherapy of the prostatic fossa Evaluation of the Ginsburg scheme: where is significant prostate cancer missed? The impact of the co-registration technique and analysis methodology in comparison studies between advanced imaging modalities and whole-mount-histology reference in primary prostate cancer Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer Comparison of manual and semi-automatic [18F]PSMA-1007 PET based contouring techniques for intraprostatic tumor delineation in patients with primary prostate cancer and validation with histopathology as standard of reference Isotropic expansion of the intraprostatic gross tumor volume of primary prostate cancer patients defined in MRI - a correlation study with whole mount histopathological information as reference Outcome after 68Ga-PSMA-11 versus choline PET-based salvage radiotherapy in patients with biochemical recurrence of prostate cancer: a matched-pair analysis Prädiktionsmodell zur Evaluierung der Detektionssicherheit für die Risikobewertung eines Prostatakarzinoms durch ausschließlich gezielte MRT/Ultraschall-Fusionsbiopsien der Prostata Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer Growth characteristics and therapeutic decision markers in von Hippel Lindau disease patients with renal cell carcinoma Exosomale AR-V7-mRNA als Biomarker zur Detektion von Resistenzen gegen Abirateron und Enzalutamid beim kastrationsresistenten Prostatakarzinom Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology Diabetes and beta adrenergic blockage are risk factors for metastatic prostate cancer Diagnostic accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before salvage lymph node dissection for recurrent prostate cancer High rates of thromboembolic events in patients with germ cell cancer undergoing cisplatin-based polychemotherapy BCG induced necrosis of the entire bladder urothelium Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer Positron emission tomography (PET) imaging of prostate Cancer with a gastrin releasing peptide receptor antagonist - from mice to men Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil Growth kinetics in Von Hippel-Lindau-associated renal cell carcinoma Therapieleitfaden Prostataerkrankungen Immunhistochemische Untersuchungen zur Wertigkeit des Nacktmausmodells für das Prostatakarzinom Die idiopathische Varikozele : Stand d. Diagnostik u. Therapie sowie krit. Würdigung d. Marburger Ergebnisse

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Wolfgang Schultze-Seemann

Comprehensive analysis of complications after transperineal prostate biopsy without antibiotic prophylaxis: results of a multicenter trial with 30 days’ follow-up

Real-world data on the use of nivolumab monotherapy in the treatment of advanced renal cell carcinoma after prior therapy: interim results from the Noninterventional NORA Study

Recruitment of activated oncogenes and their splice variants to different EV populations

Stereotactic body radiotherapy for renal cell carcinoma in patients with von Hippel–Lindau disease - results of a prospective trial

99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle

99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle

A multi-institutional analysis of prostate cancer patients with or without 68Ga-PSMA PET/CT prior to salvage radiotherapy of the prostatic fossa

A multi-institutional analysis of prostate cancer patients with or without 68Ga-PSMA PET/CT prior to salvage radiotherapy of the prostatic fossa

Evaluation of the Ginsburg scheme: where is significant prostate cancer missed?

The impact of the co-registration technique and analysis methodology in comparison studies between advanced imaging modalities and whole-mount-histology reference in primary prostate cancer

Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer

Comparison of manual and semi-automatic [18F]PSMA-1007 PET based contouring techniques for intraprostatic tumor delineation in patients with primary prostate cancer and validation with histopathology as standard of reference

Isotropic expansion of the intraprostatic gross tumor volume of primary prostate cancer patients defined in MRI - a correlation study with whole mount histopathological information as reference

Outcome after 68Ga-PSMA-11 versus choline PET-based salvage radiotherapy in patients with biochemical recurrence of prostate cancer: a matched-pair analysis

Prädiktionsmodell zur Evaluierung der Detektionssicherheit für die Risikobewertung eines Prostatakarzinoms durch ausschließlich gezielte MRT/Ultraschall-Fusionsbiopsien der Prostata

Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer

Growth characteristics and therapeutic decision markers in von Hippel Lindau disease patients with renal cell carcinoma

Exosomale AR-V7-mRNA als Biomarker zur Detektion von Resistenzen gegen Abirateron und Enzalutamid beim kastrationsresistenten Prostatakarzinom

Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer

Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology

Diabetes and beta adrenergic blockage are risk factors for metastatic prostate cancer

Diagnostic accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before salvage lymph node dissection for recurrent prostate cancer

High rates of thromboembolic events in patients with germ cell cancer undergoing cisplatin-based polychemotherapy

BCG induced necrosis of the entire bladder urothelium

Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer

Positron emission tomography (PET) imaging of prostate Cancer with a gastrin releasing peptide receptor antagonist - from mice to men

Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil

Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil

Growth kinetics in Von Hippel-Lindau-associated renal cell carcinoma

Therapieleitfaden Prostataerkrankungen

Immunhistochemische Untersuchungen zur Wertigkeit des Nacktmausmodells für das Prostatakarzinom

Die idiopathische Varikozele : Stand d. Diagnostik u. Therapie sowie krit. Würdigung d. Marburger Ergebnisse